Holen Sie sich die Stockscreener-App
13.93
0.85%
-0.12
Vorhandelsmarkt:
13.88
-0.05
-0.36%
Schlusskurs vom Vortag:
$14.05
Offen:
$14.1
24-Stunden-Volumen:
979.51K
Relative Volume:
1.07
Marktkapitalisierung:
$847.07M
Einnahmen:
$374.64M
Nettoeinkommen (Verlust:
$87.19M
KGV:
10.21
EPS:
1.365
Netto-Cashflow:
$90.65M
1W Leistung:
+1.38%
1M Leistung:
-0.21%
6M Leistung:
-2.25%
1J Leistung:
-4.52%
1-Tages-Spanne:
$13.89
$14.18
1-Wochen-Bereich:
$13.65
$14.18
52-Wochen-Spanne:
$12.72
$16.74
Inmode Ltd Stock (INMD) Company Profile
Compare INMD vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INMD
Inmode Ltd
|
13.93 | 854.36M | 374.64M | 87.19M | 90.65M | 1.365 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-28 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-17 | Eingeleitet | BTIG Research | Buy |
| 2024-07-23 | Herabstufung | Jefferies | Buy → Hold |
| 2023-11-03 | Herabstufung | UBS | Buy → Neutral |
| 2023-10-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2023-02-17 | Herabstufung | Needham | Buy → Hold |
| 2022-12-21 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-05-18 | Eingeleitet | Needham | Buy |
| 2019-09-03 | Eingeleitet | Barclays | Overweight |
| 2019-09-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-09-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-09-03 | Eingeleitet | UBS | Buy |
Alle ansehen
Inmode Ltd Aktie (INMD) Neueste Nachrichten
InMode Q1 2026 earnings preview - MSN
InMode Ltd. poised for growth with new tech, global expansion, and strong financials despite US market challenges - Pluang
InMode: My Pick For A Major Turnaround In 2026 And 2027 (NASDAQ:INMD) - Seeking Alpha
Inmode Ltd (INMD) Reports Solid Numbers in a Soft Market - Insider Monkey
[Form 3] InMode Ltd. Initial Statement of Beneficial Ownership - Stock Titan
InMode (NASDAQ: INMD) CFO lists direct, spousal shares and RSU awards - Stock Titan
15 Best Micro and Small Cap Stocks to Buy According to Jim Simons’ Renaissance Technologies - Insider Monkey
INMD Stock Price, Quote & Chart | INMODE LTD (NASDAQ:INMD) - ChartMill
Trading the Move, Not the Narrative: (INMD) Edition - Stock Traders Daily
INMD Stock Chart | INMODE LTD (NASDAQ:INMD) - ChartMill
InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Mos - GuruFocus
INMD Technical Analysis | Trend, Signals & Chart Patterns | INMODE LTD (NASDAQ:INMD) - ChartMill
Should I Buy INMD (InMode Ltd.) | AI Analysis, Technical & News Insights - Kavout
InMode names new board chairman and CFO - Investing.com UK
InMode Ltd. Announces the Appointment of Moshik Itzkovich as Chief Financial Officer, Effective May 20, 2026 - marketscreener.com
InMode Ltd. Announces the Appointment of Shlomo Nass as Chairman of the Board of Directors , Effective May 20, 2026 - marketscreener.com
InMode Names Shlomo Nass Chair; Moshik Itzkovich Appointed as CFO - Moomoo
InMode Names Moshik Itzkovich Chief Financial Officer >INMD - Moomoo
InMode names new board chairman and CFO By Investing.com - Investing.com South Africa
InMode Reshapes Leadership with New Chairman and CFO in May 2026 - TipRanks
InMode appoints Dr. Shlomo Nass as chairman of the board and Moshik Itzkovich as chief financial officer - marketscreener.com
Leadership shakeup at InMode (Nasdaq: INMD) brings new chairman and CFO - Stock Titan
InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer - Financial Times
InMode Ltd stock (IL0011356806): shares under pressure after Q1 revenue drop and cautious outlook - AD HOC NEWS
InMode Ltd stock (IL0011356806): Q1 results keep US-focused medtech in focus - AD HOC NEWS
InMode Ltd stock (IL0011356806): Recognized among top aesthetic devices leaders - AD HOC NEWS
(INMD) Volatility Zones as Tactical Triggers - Stock Traders Daily
InMode to Present at Upcoming Investor Conferences and Events - GuruFocus
InMode Ltd. to Present at Investor Conferences and Events - geneonline.com
InMode to Present at Upcoming Investor Conferences and Events – Company Announcement - Financial Times
TradingKey - TradingKey
InMode Ltd. (NASDAQ:INMD) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
InMode Is Maintained at Neutral by Baird - Moomoo
CCORF Maintains InMode(INMD.US) With Hold Rating, Maintains Target Price $15 - Moomoo
InMode Ltd. (NASDAQ:INMD) Q1 2026 Earnings Call Transcript - Insider Monkey
InMode (NASDAQ:INMD) Price Target Lowered to $14.00 at Robert W. Baird - MarketBeat
InMode Q1 2026 slides: revenue beats amid margin pressure, stock falls - Investing.com Australia
InMode Q1 2026 slides: revenue beats amid margin pressure, stock falls By Investing.com - Investing.com South Africa
InMode Share Fall After Q1 Non-GAAP Earnings Miss Estimates - Moomoo
Needham Maintains InMode(INMD.US) With Hold Rating - Moomoo
InMode (INMD) Margin Compression In Q1 2026 Reinforces Bearish Profitability Narrative - simplywall.st
InMode Ltd. Q1 2026 Earnings Call Summary - Yahoo Finance
InMode (NASDAQ:INMD) Announces Quarterly Earnings Results, Misses Expectations By $0.05 EPS - MarketBeat
InMode Q1 Earnings Call Highlights - Yahoo Finance
InMode (NASDAQ:INMD) Shares Gap Down on Disappointing Earnings - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Earnings call transcript: InMode Q1 2026 earnings miss despite revenue beat By Investing.com - Investing.com Australia
INMD: Q1 2026 revenue rose 5% to $82M, with stable outlook and active share repurchases - TradingView
Earnings call transcript: InMode Q1 2026 earnings miss despite revenue beat - Investing.com
(INMD) InMode Expects 2026 Adjusted EPS Range $1.33$1.38, vs. FactSet Est of $1.45 - marketscreener.com
(INMD) InMode Expects 2026 Revenue Range $365M$375M, vs. FactSet Est of $370M - marketscreener.com
Finanzdaten der Inmode Ltd-Aktie (INMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
1.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):